Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report

Behςet's disease (BD) is a multisystem disorder characterized by vasculitis. Pulmonary vascular problems such as pulmonary artery aneurysms (PAA) are reported to indicate poor prognosis and high mortality. We describe a 43-year-old man who presented with life threatening bilateral PAA and throm...

Full description

Saved in:
Bibliographic Details
Published in:Clinical rheumatology 2010, Vol.29 (1), p.91-93
Main Authors: Lee, Sung-Won, Lee, Sang-Yeob, Kim, Ki-Nam, Jung, Jin-Kyu, Chung, Won-Tae
Format: Article
Language:English
Subjects:
Adalimumab
Adult
Aneurysm - diagnostic imaging
Aneurysm - drug therapy
Aneurysm - etiology
Anti-Inflammatory Agents - therapeutic use
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Behcet Syndrome - complications
Behcet Syndrome - diagnostic imaging
Behcet Syndrome - drug therapy
Case Report
Cyclophosphamide - therapeutic use
Drug Therapy, Combination
Humans
Immunosuppressive Agents - therapeutic use
Male
Medicine
Medicine & Public Health
Prednisone - therapeutic use
Pulmonary Artery - diagnostic imaging
Rheumatology
Tomography, X-Ray Computed
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c394t-b3b986fb0b40771520d691d0c96187ed8d1371f8ea86e51e45606209830aec003
cites cdi_FETCH-LOGICAL-c394t-b3b986fb0b40771520d691d0c96187ed8d1371f8ea86e51e45606209830aec003
container_end_page 93
container_issue 1
container_start_page 91
container_title Clinical rheumatology
container_volume 29
creator Lee, Sung-Won
Lee, Sang-Yeob
Kim, Ki-Nam
Jung, Jin-Kyu
Chung, Won-Tae
description Behςet's disease (BD) is a multisystem disorder characterized by vasculitis. Pulmonary vascular problems such as pulmonary artery aneurysms (PAA) are reported to indicate poor prognosis and high mortality. We describe a 43-year-old man who presented with life threatening bilateral PAA and thromboembolic disease due to BD. He was treated with prednisone and pulse cyclophosphamide and was poorly responsive to the conventional immunosuppression. The introduction of adalimumab therapy stabilized his PAA. We report that the inhibition of TNF-α using the neutralizing monoclonal antibody adalimumab has the potential to induce rapid, complete, and long-lasting remission in a life-threatening manifestation of BD.
doi_str_mv 10.1007/s10067-009-1272-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_871273482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2371876451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-b3b986fb0b40771520d691d0c96187ed8d1371f8ea86e51e45606209830aec003</originalsourceid><addsrcrecordid>eNp9kM1O3TAQha2KCm4pD9BNa7FPmbGd2GZHEf2RkLqgrC0nmVyCbpKL7Sx4Ih6kL4ajXIkdGx9pfM4Z-2PsC8J3BNAXMZ-VLgBsgUKLQnxgG1RSFdYqe8Q2oDUUEq05YZ9ifAQAYSwes5M8wkqXasPoqvW7fpgHX_MUyKeBxsS7KfBd3xFPD8uMxn7c8v28G6bRh2fuQ6JFRprDcxx4P_If9PD_hRJv-0g-0iX3vMnKA-2nkD6zj53fRTo76Cm7_3nz7_p3cfv315_rq9uikValopa1NVVXQ63y07EU0FYWW2hshUZTa1qUGjtD3lRUIqmygkqANRI8NQDylJ2vvfswPc0Uk3uc5jDmlc7ojEgqI7IJV1MTphgDdW4f-iH_yyG4hatbubrM1S1c3ZL5eiie64Hat8QBZDaI1RDz1bil8Lb5vdZva6jzk_Pb0Ed3fycAJaBGVKWWr7WEjI8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>871273482</pqid></control><display><type>article</type><title>Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report</title><source>Springer Link</source><creator>Lee, Sung-Won ; Lee, Sang-Yeob ; Kim, Ki-Nam ; Jung, Jin-Kyu ; Chung, Won-Tae</creator><creatorcontrib>Lee, Sung-Won ; Lee, Sang-Yeob ; Kim, Ki-Nam ; Jung, Jin-Kyu ; Chung, Won-Tae</creatorcontrib><description>Behςet's disease (BD) is a multisystem disorder characterized by vasculitis. Pulmonary vascular problems such as pulmonary artery aneurysms (PAA) are reported to indicate poor prognosis and high mortality. We describe a 43-year-old man who presented with life threatening bilateral PAA and thromboembolic disease due to BD. He was treated with prednisone and pulse cyclophosphamide and was poorly responsive to the conventional immunosuppression. The introduction of adalimumab therapy stabilized his PAA. We report that the inhibition of TNF-α using the neutralizing monoclonal antibody adalimumab has the potential to induce rapid, complete, and long-lasting remission in a life-threatening manifestation of BD.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-009-1272-2</identifier><identifier>PMID: 19816754</identifier><language>eng</language><publisher>London: London : Springer-Verlag</publisher><subject>Adalimumab ; Adult ; Aneurysm - diagnostic imaging ; Aneurysm - drug therapy ; Aneurysm - etiology ; Anti-Inflammatory Agents - therapeutic use ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized ; Behcet Syndrome - complications ; Behcet Syndrome - diagnostic imaging ; Behcet Syndrome - drug therapy ; Case Report ; Cyclophosphamide - therapeutic use ; Drug Therapy, Combination ; Humans ; Immunosuppressive Agents - therapeutic use ; Male ; Medicine ; Medicine &amp; Public Health ; Prednisone - therapeutic use ; Pulmonary Artery - diagnostic imaging ; Rheumatology ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>Clinical rheumatology, 2010, Vol.29 (1), p.91-93</ispartof><rights>Clinical Rheumatology 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-b3b986fb0b40771520d691d0c96187ed8d1371f8ea86e51e45606209830aec003</citedby><cites>FETCH-LOGICAL-c394t-b3b986fb0b40771520d691d0c96187ed8d1371f8ea86e51e45606209830aec003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19816754$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Sung-Won</creatorcontrib><creatorcontrib>Lee, Sang-Yeob</creatorcontrib><creatorcontrib>Kim, Ki-Nam</creatorcontrib><creatorcontrib>Jung, Jin-Kyu</creatorcontrib><creatorcontrib>Chung, Won-Tae</creatorcontrib><title>Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><addtitle>Clin Rheumatol</addtitle><description>Behςet's disease (BD) is a multisystem disorder characterized by vasculitis. Pulmonary vascular problems such as pulmonary artery aneurysms (PAA) are reported to indicate poor prognosis and high mortality. We describe a 43-year-old man who presented with life threatening bilateral PAA and thromboembolic disease due to BD. He was treated with prednisone and pulse cyclophosphamide and was poorly responsive to the conventional immunosuppression. The introduction of adalimumab therapy stabilized his PAA. We report that the inhibition of TNF-α using the neutralizing monoclonal antibody adalimumab has the potential to induce rapid, complete, and long-lasting remission in a life-threatening manifestation of BD.</description><subject>Adalimumab</subject><subject>Adult</subject><subject>Aneurysm - diagnostic imaging</subject><subject>Aneurysm - drug therapy</subject><subject>Aneurysm - etiology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Behcet Syndrome - complications</subject><subject>Behcet Syndrome - diagnostic imaging</subject><subject>Behcet Syndrome - drug therapy</subject><subject>Case Report</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Prednisone - therapeutic use</subject><subject>Pulmonary Artery - diagnostic imaging</subject><subject>Rheumatology</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kM1O3TAQha2KCm4pD9BNa7FPmbGd2GZHEf2RkLqgrC0nmVyCbpKL7Sx4Ih6kL4ajXIkdGx9pfM4Z-2PsC8J3BNAXMZ-VLgBsgUKLQnxgG1RSFdYqe8Q2oDUUEq05YZ9ifAQAYSwes5M8wkqXasPoqvW7fpgHX_MUyKeBxsS7KfBd3xFPD8uMxn7c8v28G6bRh2fuQ6JFRprDcxx4P_If9PD_hRJv-0g-0iX3vMnKA-2nkD6zj53fRTo76Cm7_3nz7_p3cfv315_rq9uikValopa1NVVXQ63y07EU0FYWW2hshUZTa1qUGjtD3lRUIqmygkqANRI8NQDylJ2vvfswPc0Uk3uc5jDmlc7ojEgqI7IJV1MTphgDdW4f-iH_yyG4hatbubrM1S1c3ZL5eiie64Hat8QBZDaI1RDz1bil8Lb5vdZva6jzk_Pb0Ed3fycAJaBGVKWWr7WEjI8</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Lee, Sung-Won</creator><creator>Lee, Sang-Yeob</creator><creator>Kim, Ki-Nam</creator><creator>Jung, Jin-Kyu</creator><creator>Chung, Won-Tae</creator><general>London : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2010</creationdate><title>Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report</title><author>Lee, Sung-Won ; Lee, Sang-Yeob ; Kim, Ki-Nam ; Jung, Jin-Kyu ; Chung, Won-Tae</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-b3b986fb0b40771520d691d0c96187ed8d1371f8ea86e51e45606209830aec003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adalimumab</topic><topic>Adult</topic><topic>Aneurysm - diagnostic imaging</topic><topic>Aneurysm - drug therapy</topic><topic>Aneurysm - etiology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Behcet Syndrome - complications</topic><topic>Behcet Syndrome - diagnostic imaging</topic><topic>Behcet Syndrome - drug therapy</topic><topic>Case Report</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Prednisone - therapeutic use</topic><topic>Pulmonary Artery - diagnostic imaging</topic><topic>Rheumatology</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Sung-Won</creatorcontrib><creatorcontrib>Lee, Sang-Yeob</creatorcontrib><creatorcontrib>Kim, Ki-Nam</creatorcontrib><creatorcontrib>Jung, Jin-Kyu</creatorcontrib><creatorcontrib>Chung, Won-Tae</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Sung-Won</au><au>Lee, Sang-Yeob</au><au>Kim, Ki-Nam</au><au>Jung, Jin-Kyu</au><au>Chung, Won-Tae</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report</atitle><jtitle>Clinical rheumatology</jtitle><stitle>Clin Rheumatol</stitle><addtitle>Clin Rheumatol</addtitle><date>2010</date><risdate>2010</risdate><volume>29</volume><issue>1</issue><spage>91</spage><epage>93</epage><pages>91-93</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>Behςet's disease (BD) is a multisystem disorder characterized by vasculitis. Pulmonary vascular problems such as pulmonary artery aneurysms (PAA) are reported to indicate poor prognosis and high mortality. We describe a 43-year-old man who presented with life threatening bilateral PAA and thromboembolic disease due to BD. He was treated with prednisone and pulse cyclophosphamide and was poorly responsive to the conventional immunosuppression. The introduction of adalimumab therapy stabilized his PAA. We report that the inhibition of TNF-α using the neutralizing monoclonal antibody adalimumab has the potential to induce rapid, complete, and long-lasting remission in a life-threatening manifestation of BD.</abstract><cop>London</cop><pub>London : Springer-Verlag</pub><pmid>19816754</pmid><doi>10.1007/s10067-009-1272-2</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0770-3198
ispartof Clinical rheumatology, 2010, Vol.29 (1), p.91-93
issn 0770-3198
1434-9949
language eng
recordid cdi_proquest_journals_871273482
source Springer Link
subjects Adalimumab
Adult
Aneurysm - diagnostic imaging
Aneurysm - drug therapy
Aneurysm - etiology
Anti-Inflammatory Agents - therapeutic use
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Behcet Syndrome - complications
Behcet Syndrome - diagnostic imaging
Behcet Syndrome - drug therapy
Case Report
Cyclophosphamide - therapeutic use
Drug Therapy, Combination
Humans
Immunosuppressive Agents - therapeutic use
Male
Medicine
Medicine & Public Health
Prednisone - therapeutic use
Pulmonary Artery - diagnostic imaging
Rheumatology
Tomography, X-Ray Computed
Treatment Outcome
title Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A11%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adalimumab%20treatment%20for%20life%20threatening%20pulmonary%20artery%20aneurysm%20in%20Beh%C3%A7et%20disease:%20a%20case%20report&rft.jtitle=Clinical%20rheumatology&rft.au=Lee,%20Sung-Won&rft.date=2010&rft.volume=29&rft.issue=1&rft.spage=91&rft.epage=93&rft.pages=91-93&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-009-1272-2&rft_dat=%3Cproquest_cross%3E2371876451%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c394t-b3b986fb0b40771520d691d0c96187ed8d1371f8ea86e51e45606209830aec003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=871273482&rft_id=info:pmid/19816754&rfr_iscdi=true